Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
What’s Behind Cannabis Stock HERB? (click to learn more) Eshbal Acquires a 55% Interest in Dare to Be Different Foods (click to learn more) CSE: ALEN.U — AI Meets Digital Health (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Adagio Medical Holdings Inc ADGM

Healthcare Medical Devices
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature... see more

Recent & Breaking News (NDAQ:ADGM)

New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia

Business Wire 7 days ago

Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Business Wire 8 days ago

Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness

Business Wire December 22, 2025

Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors

Business Wire December 11, 2025

Adagio Medical Reports Third Quarter 2025 Results

Business Wire November 12, 2025

Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference

Business Wire November 5, 2025

Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia

Business Wire October 20, 2025

Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities

Business Wire October 15, 2025

Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium

Business Wire October 10, 2025

Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia

Business Wire October 1, 2025

Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium

Business Wire September 18, 2025

Adagio Medical Expands Chief Business Officer Deborah Kaster's Role to Include Chief Financial Officer Responsibilities

Business Wire September 8, 2025

Adagio Medical Reports Second Quarter 2025 Results

Business Wire August 13, 2025

Adagio Medical Reports First Quarter 2025 Results

Business Wire May 15, 2025

Adagio Medical to Present at the BofA Securities 2025 Health Care Conference

Business Wire May 7, 2025

Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

Business Wire April 17, 2025

Adagio Medical Appoints Deborah Kaster as Chief Business Officer

Business Wire March 31, 2025

Adagio Medical Reports Fourth Quarter and Full Year 2024 Results

Business Wire March 31, 2025

Adagio Medical Provides Clinical and Business Updates

Business Wire March 17, 2025

Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation

Business Wire February 28, 2025

Podcasts